| Literature DB >> 33470215 |
X Xuemin1, L Lihang1, Z Changhua1, Y Xiaofang1, N Yongshan1, L Zhipeng1, J Chong2, H Yue1.
Abstract
Entities:
Keywords: Atopic dermatitis; Efficacy; Meta-analysis; Nemolizumab; Safety
Year: 2021 PMID: 33470215 DOI: 10.18176/jiaci.0672
Source DB: PubMed Journal: J Investig Allergol Clin Immunol ISSN: 1018-9068 Impact factor: 4.333